Information Provided By:
Fly News Breaks for August 20, 2019
CPB, ABBV, BYND, CC, PPC, CACI
Aug 20, 2019 | 10:15 EDT
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pilgrim's Pride (PPC) upgraded to Outperform from Market Perform at BMO Capital with analyst Kenneth Zaslow citing the management's implementation of a "successful execution" of its chicken strategy. 2. Beyond Meat (BYND) upgraded to Overweight from Neutral at JPMorgan while Campbell Soup (CPB) was upgraded to Neutral from Underweight. 3. Chemours (CC) upgraded to Positive from Neutral at Susquehanna with analyst Don Carson saying he thinks end-user destocking of TiO2 appears to have run its course and he views the company as the prime beneficiary of an upturn in industry volumes in 2020. 4. AbbVie (ABBV) upgraded to Overweight from Neutral at Piper Jaffray with analyst Christopher Raymond saying while he remains negative on the company's decision to acquire Allergan (AGN), he believes that a bottom on the stock has been found around $66. 5. CACI (CACI) upgraded to Outperform from Neutral at Credit Suisse with analyst Robert Spingarn saying in an uncertain macro environment, he likes a defensive name that can support a multi-year story of organic growth, margin expansion, and M&A optionality, all while offering an attractive valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
News For PPC;BYND;CPB;CC;ABBV;CACI From the Last 2 Days
CACI
Sep 20, 2019 | 06:01 EDT
Barclays analyst David Strauss started CACI International with an Overweight rating and $260 price target. The analyst initiated coverage of U.S. government services and is selective on the stocks given recent outperformance, noting that valuations are now ~10% above large cap defense. The analyst, however, thinks CACI stands to benefit from further consolidation given its "proven" acquisition track record.